Hans G Lilja (Hans Lilja)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

University of Oxford

Lunds Universitet (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Oxford

United Kingdom

Professor of Clinical Biochemistry :: Nuffield Department of Surgical Sciences

University of Tampere

Finland

Finland Distinguished Professor (FiDiPro/Adjunct) :: Institute of Biomedical Technology

Memorial Sloan-Kettering Cancer Center

United States

Member, Attending Clinical Chemist :: Laboratory Medicine, Surgery, and Medicine (GU-Oncology)

Skånes universitetssjukhus Lund

Sweden

Professor (Adjunct) :: Department of Laboratory Medicine

Education History

Lunds Universitet

Sweden

PHD

Publications

Andrew Julian Vickers, Hans G Lilja
Eight Misconceptions about Prostate-Specific Antigen. Clinical chemistry 70 (1) (2024)
Andrew Julian Vickers, Hans G Lilja
Eight Misconceptions about Prostate-Specific Antigen. Clinical chemistry 70 (1) (2024)
Claire M Storey, Mohamed Altai, Mesude Bicak, Darren R Veach, Katharina Lückerath, Gabriel Adrian, Michael R McDevitt, Teja Kalidindi, Julie E Park, Ken Herrmann, Diane S Abou, Wahed Zedan, Norbert Peekhaus, Robert J Klein, Robert Damoiseaux, Steven M Larson, Hans G Lilja, Daniel L J Thorek, David Ulmert
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response. Molecular cancer research : MCR (2023)
Linda Kachuri, Thomas J Hoffmann, Yu Jiang, Sonja I Berndt, John P Shelley, Kerry R Schaffer, Mitchell J Machiela, Neal D Freedman, Wen-Yi Huang, Shengchao A Li, Ryder Easterlin, Phyllis J Goodman, Cathee Till, Ian Thompson, Hans G Lilja, Stephen K Van Den Eeden, Stephen J Chanock, Christopher A Haiman, David V Conti, Robert J Klein, Jonathan D Mosley, Rebecca E Graff, John S Witte
Genetically adjusted PSA levels for prostate cancer screening. Nature medicine (2023)
Antti Sakari Rannikko, Mare Leht, Tuomas K Mirtti, Anu Kenttämies, Teemu Tolonen, Irina Rinta-Kiikka, Tuomas P Kilpeläinen, Kari Natunen, Hans G Lilja, Terho Lehtimäki, Jani Raitanen, Paula Kujala, Johanna Ronkainen, Mika Matikainen, Anssi Petas, Kimmo Taari, Teuvo L J Tammela, Anssi Auvinen
Population-based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study. BJU international 130 (2) (2022)
Alisha J Chou, Burcu F Darst, Lynne R Wilkens, Loic Le Marchand, Hans G Lilja, David V Conti, Christopher A Haiman
Association of Prostate-Specific Antigen Levels with Prostate Cancer Risk in a Multiethnic Population: Stability Over Time and Comparison with Polygenic Risk Score. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (12) (2022)
Robert J Klein, Emily A Vertosick, Dan Sjoberg, David Ulmert, Ann-Charlotte Rönn, Christel Häggström, Elin Thysell, Göran Hallmans, Anders Dahlin, Pär Stattin, Olle Melander, Andrew Vickers, Hans G Lilja
Prostate cancer polygenic risk score and prediction of lethal prostate cancer. NPJ precision oncology 6 (1) (2022)
Martin Rasmussen, Jacob Fredsøe, Amy L Tin, Andrew J Vickers, Benedicte Ulhøi, Michael Borre, James Eastham, Behfar Ehdaie, Bertrand Guillonneau, Vincent Laudone, Peter T Scardino, Karim Touijer, Karina Dalsgaard Sørensen, Hans G Lilja
Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence. British journal of cancer 126 (7) (2021)
Darren R Veach, Claire M Storey, Katharina Lückerath, Katharina Braun, Christian von Bodman, Urpo Lamminmäki, Teja Kalidindi, Sven-Erik Strand, Joanna Strand, Mohamed Altai, Robert Damoiseaux, Pat Zanzonico, Nadia Benabdallah, Dmitry Pankov, Howard I Scher, Peter Scardino, Steven M Larson, Hans G Lilja, Michael R McDevitt, Daniel L J Thorek, David Ulmert
PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (7) (2021)
Peter E Lonergan, Emily A Vertosick, Melissa Assel, Daniel D Sjoberg, Alexander Haese, Markus Graefen, Stephen A Boorjian, George G Klee, Matthew R Cooperberg, Kim Pettersson, Erica Routila, Andrew Julian Vickers, Hans G Lilja
Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort. BJU international 128 (2) (2020)
Mesude Bicak, Katharina Lückerath, Teja Kalidindi, Michael E Phelps, Sven-Erik Strand, Michael J Morris, Caius G Radu, Robert Damoiseaux, Mari T Peltola, Norbert Peekhaus, Austin Ho, Darren R Veach, Ann-Christin Malmborg Hager, Steven M Larson, Hans G Lilja, Michael R McDevitt, Robert J Klein, David Ulmert
Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy. Proceedings of the National Academy of Sciences of the United States of America 117 (26) (2020)
Weiqiang Li, Mesude Bicak, Daniel D Sjoberg, Emily Vertosick, Anders Dahlin, Olle Melander, David Ulmert, Hans G Lilja, Robert J Klein
Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels. The Prostate 80 (16) (2020)
Burcu F Darst, Alisha Chou, Peggy Wan, Loreall Pooler, Xin Sheng, Emily A Vertosick, David V Conti, Lynne R Wilkens, Loïc Le Marchand, Andrew Julian Vickers, Hans G Lilja, Christopher A Haiman
The Four-Kallikrein Panel Is Effective in Identifying Aggressive Prostate Cancer in a Multiethnic Population. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29 (7) (2020)
Melissa J Assel, Hans David Ulmert, R Jeffery Karnes, Stephen A Boorjian, David W Hillman, Andrew J Vickers, George G Klee, Hans G Lilja
Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men. The Prostate 80 (1) (2019)
Michael R McDevitt, Daniel L J Thorek, Takeshi Hashimoto, Tatsuo Gondo, Darren R Veach, Sai Kiran Sharma, Teja Muralidhar Kalidindi, Diane S Abou, Philip A Watson, Bradley J Beattie, Oskar Vilhemsson Timmermand, Sven-Erik Strand, Jason S Lewis, Peter T Scardino, Howard I Scher, Hans G Lilja, Steven M Larson, David Ulmert
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer. Nature communications 9 (1) (2018)

Hans G Lilja.css-eqlu8i{font-size:small;padding-left:4px;} (Hans Lilja)

Publication Activity (10 Years)

Top Topics

Top Venues

Hans G Lilja (Hans Lilja)